Experiment 378974

Details

PropertyValue
Pharmacology
Administration routeIV
OrganismEmpty organism
CitationGRANT,S: ROBERTS,J: POPLIN,E: TOMBES,MB: KYLE,B: WELCH,D: CARR,M: BEAR,HD:. (1998). PHASE IB TRIAL OF BRYOSTATIN 1 IN PATIENTS WITH REFRACTORY MALIGNANCIES.. 4(3)
Amount utilized
Compound isolated
DiseasePHASE IB TRIAL 12 PATIENTS WITH REFRACTORY NON-HEMATOLOGIC MALIGNANCIES SHOWED NO RESPONSE TO TREATMENT. SIDE-EFFECTS INCLUDED MYALGIA, FEVR, ANEMIA, FATIGUE, PHLEBITIS AND HEADACHE.
Dose amount25.0 MCG
Number1
Qualitative resultINACTIVE
AnimalHUMAN ADULT
Per unitSQ M
Dose expressionDOSE